HTR1A and colorectal carcinoma: The anticancer effect of aripiprazole on CRC was achieved when HTR1A, the original target of aripiprazole, was deleted, whereas this effect was restored when LAMP2a was deficient, suggesting that LAMP2a is the key molecule for the anticancer effect of aripiprazole.